Position
Chief Financial Officer
Company
AFT Pharmaceuticals Ltd
New ZealandBiotechnologyHealth CarePharmaceuticalDescription
AFT Pharmaceuticals has announced the appointment of Stuart Houliston as its new Chief Financial Officer, effective 15 June 2026. He replaces long-serving CFO Malcolm Tubby, highlighting the importance of this transition for the company's growth strategy.
Quick answer
AFT Pharmaceuticals Appoints Stuart Houliston as Chief Financial Officer (May 18, 2026). AFT Pharmaceuticals Ltd is based in New Zealand.
- Who is the new Chief Financial Officer at AFT Pharmaceuticals Ltd?
- AFT Pharmaceuticals Ltd named Stuart Houliston Chief Financial Officer, announced May 18, 2026.
- What did AFT Pharmaceuticals Ltd announce on May 18, 2026?
- AFT Pharmaceuticals has announced the appointment of Stuart Houliston as its new Chief Financial Officer, effective 15 June 2026. He replaces long-serving CFO Malcolm Tubby, highlighting the importance of this transition for the company's growth strategy.
- What does AFT Pharmaceuticals Ltd do?
- AFT Pharmaceuticals is a New Zealand-based multinational pharmaceutical company that develops, markets and distributes a broad portfolio of proprietary and in-licensed medicines across multiple therapeutic categories.
- Where is AFT Pharmaceuticals Ltd based?
- AFT Pharmaceuticals Ltd is based in New Zealand.
- Which similar companies made leadership changes around the same time?
- Cosette Pharmaceuticals (May 19, 2026), VistaGen (May 19, 2026), OnCusp Therapeutics (May 14, 2026) and Cencora (May 27, 2026) also announced leadership changes within 45 days of AFT Pharmaceuticals Ltd.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (May 19, 2026)
- Vistagen Appoints Angel S. Angelov as Chief Medical Officer (May 19, 2026)
- OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer (May 14, 2026)
- Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer (May 27, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- GlaxoSmithKline Appoints Roanne Parry as Chief People Officer (May 8, 2026)
Who to call at AFT Pharmaceuticals Ltd, and when
A new leader at AFT Pharmaceuticals Ltd brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day AFT Pharmaceuticals Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AFT Pharmaceuticals Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AFT Pharmaceuticals Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AFT Pharmaceuticals Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AFT Pharmaceuticals Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.